Top Markets
Coin of the day
AmCad BioMed Corporation AmCad BioMed Corporation

AmCad BioMed Corporation

4188
Clasificación en acciones #29619
AmCad BioMed Corporation develops computer-aided detection and diagnosis (CAD)... AmCad BioMed Corporation develops computer-aided detection and diagnosis (CAD) software devices primarily in Taiwan. It offers products for early detection and diagnosis of various diseases. The company's products include AmCAD-UT Detection, a CAD device for ultrasound images of thyroid nodules; and AmCAD-UO for detection of obstructive sleep apnea on awake patients. It also developing AmCAD-US, a software device for visualizing and quantifying statistical distributions of backscattered signals echoed by tissue compositions in the body from FDA-cleared ultrasound systems; and AmCAD-UB, an AI Solution for Breast Lesion Detection. The company was incorporated in 2008 and is based in Taipei City, Taiwan.
Precio por acción
$0.32117018
Capitalización bursátil
$20.34M
Cambio (1 día)
-0.98%
Cambio (1 año)
-34.41%
País
TW
Comercio AmCad BioMed Corporation (4188)

Categoría

Ratio P/B de AmCad BioMed Corporation (4188)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de AmCad BioMed Corporation, el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de AmCad BioMed Corporation desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
3.8194 -
DE
- -
CA
4.9747 -
US
5.6622 -
US
10.2343 -
US